Renal dysfunction is a common problem in cardiac transplant recipients who receive the immunosuppressive agent cyclosporine. Elevation in serum creatinine levels and other indicators of renal dysfunction often appear during the first year after transplant. Related problems of hypertension and gout also arc common. Specific strategies to minimize the nephrotoxic effects of cyclosporine and other potential insults to renal function can be used by nurses, physicians, and other health team members. Preservation of renal function enhances a patient’s overall functional status and improves survival and quality of life for cardiac transplant recipients
Renal Replacement| August 01 1992
Monitoring and Prevention of Renal Dysfunction in Cardiac Transplant Recipients
Diane K. Dressler, RN, MSN, CCRN, CCTC
From the Midwest Heart Surgery Institute, Ltd., Milwaukee, Wisconsin.
Reprint requests to Diane K. Dressler, RN, MSN, CCRN, CCTC, Midwest Heart Surgery Institute, Ltd., 2901 W. Kinnickinnic River Parkway, Milwaukee, WI 53215.
Search for other works by this author on:
AACN Adv Crit Care (1992) 3 (3): 633–639.
- Views Icon Views
- Share Icon Share
Diane K. Dressler; Monitoring and Prevention of Renal Dysfunction in Cardiac Transplant Recipients. AACN Adv Crit Care 1 August 1992; 3 (3): 633–639. doi: https://doi.org/10.4037/15597768-1992-3009
Download citation file: